Geriatric Thoracic Surgery Ambulation Challenge
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorDana-Farber Cancer Institute
About this trial
This study is examining collecting data on steps walked (ambulation) per day by thoracic surgery patients over the age of 65 years-old before surgery.
The name(s) of the study device involved in this study is:
* Fitbit inspire
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients Aged ≥ 65 years
Who are preparing to undergo thoracic surgery at Brigham and Women's Hospital (BWH)
Disqualifiers
Patients who are completely non-ambulatory (i.e. wheelchair-bound-patients) *
Those who lack capacity to consent due to cognitive disease.
Patient for which surgery is felt to be more urgent and therefore performed earlier then our required timeframe for intervention.
Patients with cardiac disease or angina for which formal cardiac testing is required for clearance.
Trial design
Design model
Single group
Treatments tested in this trial
Fitbit
BehavioralElectronic activity tracker
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: PRE-OPERATIVE EXERCISE TRACKINGExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Step Tracking Rate
Feasibility will be determined by the successful tracking of steps and keeping a diary of step-count for one-week duration. Completion of a minimum of 5/7 days will be considered as a success
Time frame
1 week2
Diary of Steps Rate
Feasibility will be determined by the successful tracking of steps and keeping a diary of step-count for one-week duration. We will consider completion of a minimum of 5/7 days as a success.
Time frame
1 week3
Return Rate
If 90% of trackers are returned, it will be considered a successful return.
Time frame
1 week4
Data Retrieval Rate
assess extraction of the data from the mobility upon return. Success will be considered if 90% of data is retrievable
Time frame
1 weekSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov